Osseointegration of THA Grafted by PolyNASS (ACTISURF-CERAFIT® ) Versus Non-grafted THA (CERAFIT®)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Thomas Bauer, MD, PhD
Hospital Ambroise Paré Paris
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chu de Bordeaux Site Pellegrin
Bordeaux, France
- Hopital Ambroise Pare
Boulogne-Billancourt, France
- Ch Privé Brestois Et Clinique Pasteur
Brest, France
- Chu Cavale Blanche
Brest, France
- Hôpital Lariboisière
Paris, France
- Ch de Cornouaille
Quimper, France
- Hus
Strasbourg, France
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 8 May 2017
- Primary completion
- 31 Dec 2024
- Completion
- 31 Dec 2039
- Last update posted
- 22 Dec 2025
- Registered enrollment
- 340
- Registry id
- NCT03113981
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.